Lv32
370 积分 2025-09-10 加入
Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis
1天前
已完结
Biologic degraders push forward in the clinic
1天前
已完结
Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). I. Drugs in preclinical and early clinical development
27天前
已完结
Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
1个月前
已完结
Drug discovery and development in idiopathic pulmonary fibrosis: the changing landscape
1个月前
已完结
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
1个月前
已完结
Microglial phagocytosis in Alzheimer disease
1个月前
已完结
Improvement of pharmacokinetic properties of therapeutic antibodies by antibody engineering
1个月前
已完结
Therapeutic effect of IL-11 inhibition on the pathogenesis of thyroid eye disease
1个月前
已关闭
Immunology of human fibrosis
1个月前
已完结
皖公网安备34019202002308
